Vancomycin dosing in patients on intermittent hemodialysis
Stefaan J Vandecasteele1, An S De Vriese
1Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium. Stefaan.Vandecasteele@azsintjan.be
Seminars in Dialysis
|February 23, 2011
Summary
Optimizing vancomycin dosing in dialysis patients is crucial to prevent treatment failure and antibiotic resistance. Achieving target vancomycin trough levels (15-20 μg/ml) requires careful consideration of individual patient factors and dialysis parameters.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Vancomycin is essential for treating gram-positive infections in dialysis patients.
- Subtherapeutic levels risk treatment failure and resistance; supratherapeutic levels increase nephrotoxicity and ototoxicity.
- A narrow therapeutic range (15-20 μg/ml trough levels) is recommended.
Purpose of the Study:
- To review vancomycin dosing considerations in hemodialysis patients.
- To highlight factors influencing vancomycin levels and therapeutic targets.
- To address the lack of evidence on optimal maintenance dosing.
Main Methods:
- Review of current literature on vancomycin pharmacokinetics in dialysis patients.
- Analysis of factors affecting vancomycin levels, including administration timing, filter type, and dialysis duration.
- Consideration of patient-specific factors like body weight, interdialytic interval, and residual renal function.
Main Results:
- Vancomycin dosing is influenced by administration timing, filter type, dialysis duration, body weight, interdialytic interval, and residual renal function.
- A weight-based loading dose of 20-25 mg/kg is recommended, similar to patients with normal kidney function.
- Most fixed-dose maintenance regimens do not achieve target vancomycin levels in hemodialysis patients.
Conclusions:
- Optimal vancomycin maintenance dosing in hemodialysis patients remains an area requiring further investigation.
- Individualized dosing strategies are necessary to achieve therapeutic vancomycin levels and minimize toxicity.
- Further research is needed to establish evidence-based optimal maintenance dosing regimens.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Hemodialysis III: Nursing Management
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...